About 6,960,000 results
Mepolizumab reduces exacerbations in COPD with type 2 …
GSK announces positive results from phase III trial of Nucala ...
Mepolizumab Significantly Reduces COPD Exacerbations
GSK announces FDA approval for Nucala (mepolizumab) for …
FDA Approves First Drug to Treat Group of Rare Blood Disorders in ...
GSK announces phase III results published in NEJM of mepolizumab …
Benralizumab versus Mepolizumab for Eosinophilic …
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary …
Mepolizumab Lessens Exacerbations, Improves Quality of Life
Oral Glucocorticoid-Sparing Effect of Mepolizumab in …